Japanese company profile · 7096

StemCell Institute Inc.

English company name recorded in Japan's EDINET filer data.

Original Japanese company name: 株式会社ステムセル研究所

Name follows the English name recorded in EDINET filer data. English company name source

FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-23

What does this company do?

What does this company do?

In its FY2025 public filing, StemCell Institute Inc. reports Cell banks. The page shows business-level revenue and profit where the source disclosures support comparison.

StemCell Institute Inc.'s largest reported business by revenue in FY2025 was Cell banks.

The business with the highest reported segment profit in FY2025 was Cell banks.

FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥2.81B ↗
FY2025 · fiscal year ended March 2026
Operating profit
¥202.66M ↗
FY2025 · fiscal year ended March 2026
Comparable margin
7.2% ↗
FY2025 · fiscal year ended March 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
7096
EDINET code
E35563
Corporate number
8010401038548
Listing status
Listed
Industry (EDINET filer classification)
Pharmaceuticals

Location and fiscal year

Headquarters
東京都港区 · As filed in Japanese
Fiscal year end
3month
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
136 people (FY2025)
Employees (non-consolidated)
120 people (FY2025)
Capital stock
JPY 704.8 million (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Cell banks

FY2025 · fiscal year ended March 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Cell banks¥2.81B ↗—¥202.66M ↗7.2%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

JGAAP · Consolidated
  1. FY2025100.0¥2.81B

Company revenue

JGAAP · Parent-only
  1. FY202166.5¥1.78B
  2. FY202278.1¥2.09B
  3. FY202392.6¥2.48B
  4. FY2024100.0¥2.68B

Company operating profit

JGAAP · Consolidated
  1. FY2025100.0¥202.66M

Company operating profit

JGAAP · Parent-only
  1. FY202154.2¥226.95M
  2. FY202271.1¥297.56M
  3. FY202398.9¥413.76M
  4. FY2024100.0¥418.51M

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

What has changed?

What has changed?

Not disclosed or not safely comparable in the available filings.

What is growing?

What is growing?

No comparable reported revenue growth is available.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth—
    No comparable data
  • Profitability59
    Position among all companies with available values in the fixed reference data.FY2025
  • Business concentration—
    No comparable data
  • Business change—
    No comparable data
  • Cash generation—
    No comparable data
  • Growth persistence79
    Peer-position scoreFY2021→FY2022, FY2022→FY2023, FY2023→FY2024

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YI32

View original filing ↗

根拠となる資料